2019 Announcements

CLINUVEL
Posted by CLINUVEL
March 4, 2019

Investor Briefing

4 March 2019 Investor Briefing – Non-Deal Roadshow Download PDF to read...

Read More
CLINUVEL
Posted by CLINUVEL
February 26, 2019

Appendix 4D Half Yearly Report

Melbourne, Australia, 26 February 2019 CLINUVEL PHARMACEUTICALS LTD, a global biopharmaceutical company...

Read More
CLINUVEL
Posted by CLINUVEL
February 12, 2019

CLINUVEL Vitiligo Communiqué II

12 February 2019   In the second Communiqué we look closer at...

Read More
CLINUVEL
Posted by CLINUVEL
February 7, 2019

CLINUVEL Newsletter - February 2019

7 February 2019 Dear patients, shareholders, friends, In this second Communiqué for...

Read More
CLINUVEL
Posted by CLINUVEL
January 31, 2019

Appendix 4C

31 January 2019 Melbourne, Australia and Leatherhead, UK CLINUVEL PHARMACEUTICALS LTD, a...

Read More
CLINUVEL
Posted by CLINUVEL
January 29, 2019

Change of Director's Interest Notice

Melbourne, Australia 29 January 2019 The following Appendix 3Y Change of Director’s...

Read More
CLINUVEL
Posted by CLINUVEL
January 15, 2019

CLINUVEL Newsletter - January 2019

15 January 2019 Dear patients, shareholders, friends, I wish you all a...

Read More
CLINUVEL
Posted by CLINUVEL
January 10, 2019

US FDA sets PDUFA date for SCENESSE®

Melbourne, Australia 10 January 2019 Priority Review granted for innovative drug, PDUFA...

Read More
We use cookies to give you the best experience.